Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway
Loading...
Date
Authors
Oyagbemi, Ademola Adetokunbo
Omobowale, Temidayo Olutayo
Adejumobi, Olumuyiwa Abiola
Owolabi, Abiodun Mary
Ogunpolu, Blessing Seun
Falayi, Olufunke Olubunmi
Hassan, Fasilat Oluwakemi
Ogunmiluyi, Iyanuoluwa Omolola
Asenuga, Ebunoluwa Racheal
Ola-Davies, Olufunke Eunice
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Please read abstract in the article.
Description
Keywords
Hypertension (HTN), Oxidative stress, Naringenin, Novel-antihypertensive agent, SDG-03: Good health and well-being, Antihypertensive power, Mineralocorticoid receptor (MCR), Angiotensin converting enzyme (ACE), Kidney injury molecule (Kim-1)
Sustainable Development Goals
Citation
Oyagbemi, A.A., Omobowale, T.O., Adejumobi, O.A. et al. 2020, 'Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway', European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142.